Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
Développer la qualité dans le champ sanitaire, social et médico-social
Logo
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. CEDACONDA (isoflurane)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • Établissements de santé
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

CEDACONDA (isoflurane)

Medicine - Posted on Mar 24 2026
Active substance (DCI)
  • isoflurane
history (2)
  • 2/18/26

    CEDACONDA (isoflurane) - Sédation chez les patients pédiatriques à partir de 3 ans

    L'essentiel Avis favorable au remboursement dans « la sédation des patients pédiatriques à partir de 3 ans sous ventilation ...
    CAV :
    54321
    icône flèche
  • 2/16/22

    CEDACONDA (isoflurane)

    Key points Favourable opinion for reimbursement in the sedation of ventilated adult patients during intensive care. What the...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • N01AB06
Manufacturer
MEDIPHA SANTE
Presentation

CEDACONDA 100% V/V, liquide pour inhalation par vapeur
6 flacons (verre brun) de 100 mL (CIP : 34009 550 833 8 2)
6 flacons (verre brun) de 250 mL (CIP : 34009 550 833 9 9)

All our publications
    Anaesthesia, sedation, analgesia Drug therapy Paediatrics

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
PnZd8YYUvL1w6QSN